When The New England Journal of Medicine published an analysis showing that Avandia increased the risk of heart attacks by more than a third, Congress held hearings, and sales of the drug dropped 20%.
In a strongly worded editorial, the New England Journal of Medicine took issue with an analysis that had dismissed a link between an active ingredient in the pills and cancer.
No sports medicine, pediatric or legal expert analysis was provided, and no one qualified to talk on any of those matters presented themselves as such according to the sources.
FORBES: Philadelphia Catholic Church Lifts Ban On Females Playing Football
Bottom line, there are places in life where technology and human analysis are both essential, and medicine is certainly one of them.
FORBES: Damn That Was Scary! Reflections On The Irrelevance of VCs & The Fallibility Of Technology
But in a third analysis of research in biology and medicine, though, China barely made a dent, with the United Kingdom coming in a distant second to the U.S.. SciVal says American researchers published 250, 000 scientific papers on biology or medicine, 29% of the global total, in 2009.
FORBES: China Passed The U.S. In Information Technology. What's Next?
Nissen helped start the debate over diabetes drugs a year ago with an analysis in the New England Journal of Medicine that alleged that Avandia, then the top-selling diabetes medicine, actually boosted the risk of heart attacks.
Gregg W. Stone, a professor of medicine at Columbia University and the author of an analysis of Boston Scientific's stent published in the New England Journal, says that is worried that doctors have pulled back too much from using drug coated stents, in even off-label uses.
The most recent analysis, published in the Annals of Internal Medicine, reports that salmeterol increases the risk of hospitalization for any form of asthma.
GlaxoSmithKline's own analysis of its diabetes drug Avandia showed that the medicine increased the risk of heart attacks by a third.
In May 2007, my colleague Kathy Wolski and I published an independent analysis of Avandia in the New England Journal of Medicine (NEJM), showing a statistically significant 43% increase in heart attack.
FORBES: Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings
Sir Richard Peto, the renowned British statistician who conducted an analysis showing "no credible evidence" that the cholesterol medicine Vytorin causes cancer, defended himself in a sharply worded letter to congressmen investigating the medicine.
The results, published in the prestigious Journal of the American Medical Association, are not new but a re-analysis of the data that was used to get the medicine, Natrecor, approved by the U.S. Food and Drug Administration.
However, Peto does not address criticisms of his analysis made in two separate editorials in the New England Journal of Medicine, which made more nuanced arguments that an increase in the risk of cancer death from Vytorin cannot be dismissed (see: "Top Statistician Says Vytorin Cancer Risk 'Not Ruled Out'").
The biggest-selling diabetes drug in the world dramatically increases the risk of heart attacks and death from heart problems, according to an analysis by a top cardiologist published online in The New England Journal of Medicine.
Students will help improve Watson's language and domain analysis capabilities by judging the evidence it provides and analyzing its answers within the domain of medicine.
ENGADGET: Cleveland Clinic and IBM team up to make Watson a Doctor (video)
But the standard in medicine is usually to include the drop-outs, raising the bar for new drugs, and this was the analysis pre-specified in the SHARP protocola nd the one Merck presented.
应用推荐